title: Antithrombogenic surfaces: characterization and bioactivity of surface immobilized PGE1-heparin conjugate.
abstract: A covalently bonded conjugate of commercial grade heparin and prostaglandin E1 (PGE1) was synthesized to prevent both fibrin formation and platelet aggregation during thrombus formation. The PGE1-heparin conjugate was immobilized on an imidazole carbamate derivatized sepharose bead surface through hydrophilic spacer groups (diamino-terminated polyethylene oxides). One end of the spacer group was coupled to the derivatized surface through a urethane bond between the amine group of the spacer and the derivatized surface. The free amine group of the immobilized spacers was coupled to a carboxylic group of the PGE1-heparin conjugate through an amide bond. Bioactivity of the immobilized conjugate (heparin activity) was measured in terms of increased clotting times (thrombin time assay) and for the inactivation of Factor Xa. Bioactivity of the immobilized compound (PGE1 activity) was analyzed by platelet adhesion and platelet release reactions using C14-5-hydroxytryptamine (5-HT). The conjugate immobilized via the C2 spacer showed the highest incidence of platelet adhesion, 5-HT released and the lowest activity for coagulation factors. In contrast, the 1000 and 4000 immobilized systems showed a significant reduction in platelet activation, while having the greatest effect on coagulation factors. The results of these experiments imply that the immobilized conjugate is active in preventing both pathways of thrombus formation, and the efficacy is improved through the use of long-chain hydrophilic spacer groups.
authors.affiliation: Department of Pharmaceutics, University of Utah, Salt Lake City 84108.
authors.forename: H A
authors.initials: HA
authors.lastname: Jacobs
authors.forename: T
authors.initials: T
authors.lastname: Okano
authors.forename: S W
authors.initials: SW
authors.lastname: Kim
mesh_terms: D000527:Alprostadil; D000818:Animals; D001672:Biocompatible Materials; D001780:Blood Coagulation Tests; D005337:Fibrin / Q000096:biosynthesis*; D006493:Heparin; D008297:Male; D010973:Platelet Adhesiveness; D010974:Platelet Aggregation / Q000187:drug effects*; D010975:Platelet Aggregation Inhibitors; D011817:Rabbits; D013918:Thrombin Time
chemical_list: D001672:Biocompatible Materials; D010975:Platelet Aggregation Inhibitors; D005337:Fibrin; D006493:Heparin; D000527:Alprostadil